Company
United StatesPublic company, NASDAQ: DXCMDexcom, Inc. (NASDAQ: DXCM), Mesa, AZ – FDA Inspections
Inspection records and compliance data for Dexcom, Inc. in Mesa, Arizona. 2 FDA inspections on record, 1 Form 483, last inspected June 14, 2024. Publicly traded as NASDAQ: DXCM.
Company Profile
This profile covers Dexcom, Inc. based in Mesa, Arizona, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected March 22, 2018. Last inspected June 14, 2024.
Most cited issue areas
- Documentation1 inspection
- Lack of or inadequate procedures1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 14, 2024 | Not classified | Medical Devices & Rad Health · Compliance: Devices | 1235499 |
| March 22, 2018 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1047034 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Dexcom, Inc.
Stock ticker
DXCM
Exchange
NASDAQ
Share price
$81.39
Market cap
$30.4B
Price as of
November 13, 2026
FEI Number
3013435121
Address
232 South Dobson Road, Mesa, Arizona 85202, United States
Country
United States
ID: 951d0c4e-48b6-4963-9475-c905cf7fbf75